Brandon BioCatalyst

Brandon BioCatalyst

Overview

Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand, managed by Brandon Capital. It is a collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments, and more than 50 leading medical research institutes and hospitals, focused on developing and commercializing early-stage biomedical discoveries.

Year Founded

2007

Portfolio Companies

3

Investments

CompanyDateStageLead
CytophenixSep 2024GrantCo-investor
CytophenixMay 2023GrantCo-investor
Amaroq TherapeuticsJul 2021SeedCo-investor
Okogen, Inc.Feb 2018Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMelbourne
Year Founded2007

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.